ArticleFrontiers in public health2026
Public health determinants of screening accessibility, diagnostic and treatment timeliness, care adherence, and survival outcomes in breast cancer patients.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Disparities in public health infrastructure, healthcare access, and system-level support contribute to delays in breast cancer screening, diagnosis, treatment initiation, and adherence to care, leading to advanced-stage presentation and poorer survival, particularly among rural and underserved populations. Aim: To evaluate the influence of individual, community, and health system level determinants on screening access, timeliness of diagnosis and treatment, adherence to therapy, and survival outcomes among women with breast cancer. Methods: This retrospective cohort study included 1,100 women diagnosed with primary breast cancer between January 2022 and December 2024. Data were obtained from hospital records, cancer registries, and administrative databases. Screening history, diagnostic and treatment intervals, treatment adherence, and survival were assessed. Multivariable logistic regression identified determinants of screening access, diagnostic and treatment delays, and treatment non-completion, while Cox proportional hazards models evaluated survival after adjustment for confounders. Results: Over one-third of patients had never undergone prior screening, and 25% traveled more than 25 km to access services, indicating that geographic and access barriers may contribute to delayed diagnosis and poorer survival. Diagnostic delays exceeding 60 days occurred in nearly one-third of patients, and one-quarter experienced treatment initiation delays. Overall treatment adherence was 72.1%, with lower adherence among uninsured patients. Integrated pathway analysis identified a low-access group (28.3%) characterized by absent screening, who had prolonged delays at each stage of care and a 32.5% mortality at follow-up, and reduced survival, whereas the high-access group demonstrated >90% survival at follow-up. Geographic, financial, and system-level barriers were independently associated with delays, treatment non-completion, and poorer survival. In contrast, care at tertiary centers and patient navigation support were significantly associated with improved timeliness, adherence, and survival outcomes. Conclusion: Social and system-level determinants exert cumulative effects across the breast cancer care continuum. Strengthening healthcare access, expanding patient navigation, and enhancing system coordination may reduce delays, improve adherence, and improve survival.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.